news and views
New collaboration with JeNaCell – part of Evonik
Exclusive distribution of epiciteĀ® in German market Proprietary manufacturing process from JeNaCell based on biosynthetic cellulose Hydrogel-alternative for outpatients with chronic wounds Jena, GermanyEvonik has signed an agreement with the medical technology...
2nd COMPANY CONTRACT SIGNED
After a year of analyzing more than 40 start-up cases, we have signed the 2nd principal contract. Exelderma, a Portuguese company, has developed an innovative cream to regenerate the skin. It contains five growth factors known for their importance in wound healing,...
Coopmed established
After 8 months of preparation, Coopmed was finally established on August 20, 2020. Now, we can get in closer dialogue with relevant MedTech start-ups and support the ones that share our view on one of the main reasons for the low success rates. Reasons that also...